Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy

OBJECTIVES: Immune checkpoint inhibitors (ICIs) alone or combined with other antitumor agents are largely used in lung cancer patients, which show both positive effects and side effects in particular subjects. Our study aims to identify biomarkers that can predict response to immunotherapy or risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wei-Ting, Zhang, Qiurui, Zhang, Ze, He, Xuan, Zhou, Min, Guo, Yi, Wang, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025375/
https://www.ncbi.nlm.nih.gov/pubmed/36949952
http://dx.doi.org/10.3389/fimmu.2023.1112409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025375/
https://www.ncbi.nlm.nih.gov/pubmed/36949952
http://dx.doi.org/10.3389/fimmu.2023.1112409

Ejemplares similares